COX-2 and cancer: a new approach to an old problem

被引：106
作者：
Bakhle, YS [1 ]
机构：
[1] Univ London Imperial Coll Sci & Technol, Fac Med, Div Biomed Sci, London SW7 2AZ, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2001年 / 134卷 / 06期
关键词：
angiogenesis; APC; apoptosis; aspirin; breast; (cancer); carcinogenesis; chemoprevention; chemotherapy; colorectal; (cyclo-oxygenase); cytokines; epidemiology; FAP; HNPCC; lung; Min mouse; NSAID; PPAR; prostate; sulindac; thiazolidinedione;
D O I：
10.1038/sj.bjp.0704365
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1137 / 1150
页数：14
相关论文
共 50 条
  • [31] Combination of EGFR and COX-2 inhibitors in breast cancer patient
    Wiwanitkit, Viroj
    TUMOR BIOLOGY, 2012, 33 (04) : 1261 - 1261
  • [32] Association Between COX-2 Polymorphisms and Lung Cancer Risk
    Wang, Weiwei
    Fan, Xinyun
    Zhang, Yong
    Yang, Yi
    Yang, Siyuan
    Li, Gaofeng
    MEDICAL SCIENCE MONITOR, 2015, 21 : 3740 - 3747
  • [33] Design and Synthesis of New 1,3-Benzdiazinan-4-one Derivatives as Selective Cyclooxygenase (COX-2) Inhibitors
    Zarghi, Afshin
    Zebardast, Tannaz
    Hajighasemali, Fatemeh
    Alipoor, Eskandar
    Daraie, Bahram
    Hedayati, Mehdi
    ARCHIV DER PHARMAZIE, 2012, 345 (04) : 257 - 264
  • [34] Is COX-2 inhibition a panacea for cancer prevention?
    Vainio, H
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (05) : 613 - 614
  • [35] Change in Nicotine-Induced VEGF, PGE2 AND COX-2 Expression Following COX Inhibition in Human Oral Squamous Cancer
    Salimi, Mona
    Esfahani, Masoumeh
    Habibzadeh, Narcis
    Aslani, Hamid Reza
    Amanzadeh, Amir
    Esfandiary, Mehrangiz
    Sedaghati, Bita
    Bidgoli, Sepideh Arbabi
    Ghahremani, Mohammad Hossein
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2012, 31 (04) : 349 - 356
  • [36] Is COX-2 a 'collateral' target in cancer prevention?
    Kashfi, K
    Rigas, B
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 : 724 - 727
  • [37] Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk
    Ashok, Varun
    Dash, Chiranjeev
    Rohan, Thomas E.
    Sprafka, J. Michael
    Terry, Paul D.
    BREAST, 2011, 20 (01) : 66 - 70
  • [38] COX-2 inhibitor as a radiation enhancer - New strategies for the treatment of lung cancer
    Saha, D
    Pyo, H
    Choy, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S70 - S74
  • [39] Chemoprevention strategies using NSAIDs and COX-2 inhibitors
    Keller, JJ
    Giardiello, FM
    CANCER BIOLOGY & THERAPY, 2003, 2 (04) : S140 - S149
  • [40] Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
    Barnes, N
    Haywood, P
    Flint, P
    Knox, WF
    Bundred, NJ
    BRITISH JOURNAL OF CANCER, 2006, 94 (02) : 253 - 258
12345